Familial Lipoprotein Lipase Deficiency Latest Advances
Find the Latest Research About Familial Lipoprotein Lipase Deficiency
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 867 publications
Comparative efficacy and safety of olezarsen versus volanesorsen for familial chylomicronemia syndrome: a matching-adjusted indirect comparison.
Journal: Journal of comparative effectiveness research
Published: June 19, 2026
Heterozygosity for pathogenic variants in familial chylomicronemia syndrome genes: from carrier state to complex trait.
Journal: Current opinion in lipidology
Published: June 17, 2026
A Case of Familial Chylomicronemia Syndrome Caused by a Novel Homozygous GPIHBP1 Mutation Successfully Treated with the Selective PPARα Modulator Pemafibrate.
Journal: Journal of atherosclerosis and thrombosis
Published: June 17, 2026
ApoC[III] You Later: A Review of Plozasiran for the Management of Familial Chylomicronemia Syndrome.
ApoC[III] You Later: A Review of Plozasiran for the Management of Familial Chylomicronemia Syndrome.
Journal: The Annals of pharmacotherapy
Published: June 06, 2026
Clinical identification of familial chylomicronemia syndrome and novel therapeutic options.
Journal: Expert review of cardiovascular therapy
Published: April 20, 2026
Plozasiran (Redemplo) for familial chylomicronemia syndrome.
Journal: The Medical letter on drugs and therapeutics
Published: April 10, 2026
The Approval of Redemplo for Familial Chylomicronemia Syndrome and the Many Flavors of GalNAc-Oligonucleotides.
Journal: Nucleic acid therapeutics
Published: March 25, 2026
The evaluation of plozasiran for the treatment of familial chylomicronemia syndrome.
Journal: Expert review of endocrinology & metabolism
Published: March 20, 2026
Functional characterization of Furin-mediated lipoprotein lipase cleavage.
Journal: Disease models & mechanisms
Published: February 26, 2026
Fresh frozen plasma as functional replacement therapy in early infantile ApoC-II deficiency: a molecularly confirmed case series.
Journal: Journal of pediatric endocrinology & metabolism : JPEM
Published: February 24, 2026
Comparative efficacy and safety of olezarsen vs plozasiran for familial chylomicronemia syndrome: A matching-adjusted indirect comparison.
Journal: Journal of clinical lipidology
Published: February 17, 2026
Last Updated: 06/30/2026